Brain stimulation study for chronic pain including post-COVID
Part of Infections, Lungs & breathing, Pain clinical trials.
This study tests if a non-invasive brain stimulation technique can reduce pain in people with chronic pain conditions like fibromyalgia, headaches, or pain that started after COVID-19. It is looking for healthy people and people with ongoing pain to see if the treatment helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You have had chronic pain (fibromyalgia, headaches, a type of stomach pain, post-COVID pain, or general muscle/joint pain) for more than 3 months.
- If you have post-COVID pain, your symptoms started after your infection and have lasted at least 12 weeks.
- You do not have any of the following: heart disease, diabetes, epilepsy (or a close family member with it), dizziness problems, or a history of chronic pain or fatigue before COVID.
- You are not pregnant, do not drink alcohol heavily, and do not use recreational drugs.
- You are not currently ill with COVID-19 or have a fever.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized form of brain stimulation (high-definition tDCS) to treat chronic pain that has not improved with other treatments. If you have had pain for at least 6 months and it is still moderate to severe, this may be an option to explore.
This study tests a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (TMS), to see if it can help people who have both major depression that hasn't improved with medication and chronic pain from fibromyalgia or chronic fatigue syndrome. It aims to reduce both depression and pain symptoms.
This study tests whether personalized sessions of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help reduce chronic pain. It aims to understand how this treatment works and how it might be tailored to individuals.
This trial uses a gentle brain stimulation technique called tDCS to see if it can reduce chronic pain in people with certain pain conditions. You would self-administer the treatment and report your results.
This study tests whether a non-invasive brain stimulation treatment (rTMS) can reduce chronic pain in fibromyalgia patients. The treatment uses magnetic pulses to stimulate specific areas of the brain and may help relieve widespread pain.
This study tests a type of brain stimulation (called accelerated neuromodulation) to see if it can help veterans who have both PTSD and chronic pain. It uses a device placed on the scalp to gently stimulate brain areas linked to these conditions, with the goal of reducing symptoms.
Hear when a new Post-COVID Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.